Table 1 Patients’ characteristics at baseline
Variable | Study cohort (n = 24) |
|---|---|
Sex (ref. Male; n, %) | 20 (83.3) |
Age at transplant (years) | 58 ± 12.5 |
Weight (kg) | 74 ± 15.6 |
BMI (kg/m2) | 24.7 ± 4.73 |
Systolic BP (mmHg) | 119 ± 19.6 |
Diastolic BP (mmHg) | 68 ± 12.4 |
Heart rate (apm) | 90 ± 14.7 |
Creatinine (μMol/L) | 121 ± 69.1 |
eGFR (mL/min) | 65 ± 28.5 |
AST (U/L) | 30 ± 14.7 |
ALT (U/L) | 34 ± 27.7 |
LV ejection fraction (%) | 63 ± 5.0 |
TAPSE (mm) | 18 ± 3.4 |
sPAP (mmHg) | 31 ± 8.9 |
Valvular diseasea (ref. Yes; n, %) | 11 (54.2) |
NYHA Class | |
Class I (n, %) | 23 (95.8) |
Class II (n, %) | 1(4.2) |
Follow-up period (days) | 303 [248; 362] |
Follow-up visit interval (days) | 28 [14; 35] |
Rejection episodes | |
Grade 0 | 181 (63.5) |
Grade 1A/B | 80 (28.1) |
Grade 2 | 10 (3.5) |
Grade 3A | 14 (4.9) |